Skip to main content
. 2017 Oct 25;33(8):1389–1396. doi: 10.1093/ndt/gfx275

Table 4.

Adjusted HRs for study outcomes in the non-CKD subgroup according to SMg tertiles (mg/dL)

Model 1
Model 2
Model 3
HR 95% CI P value HR 95% CI P value HR 95% CI P value
All-cause death
 Low SMg 2.09 1.47–2.98 <0.001 1.54 1.03–2.33 0.04 1.30 0.86–1.96 0.22
 Medium SMg 1.38 0.99–1.92 0.06 1.26 0.88–1.82 0.21 1.24 0.86–1.79 0.25
 High SMg Ref. Ref. Ref.
CV death or event
 Low SMg 1.29 0.91–1.84 0.16 1.22 0.83–1.79 0.31 1.06 0.72–1.57 0.77
 Medium SMg 1.06 0.78–1.44 0.69 0.99 0.71–1.37 0.95 1.01 0.73–1.41 0.94
 High SMg Ref. Ref. Ref.

SMg, serum magnesium; CV, cardiovascular; HR, hazard ratio; 95% CI, 95% confidence interval. HR of the low versus high SMg level. eGFR was calculated according to the MDRD study equation. CKD was defined as eGFR <60 mL/min/1.73 m2 and/or ACR >17 mg/g in men and >25 mg/g in women.

Model 1 was adjusted for age, gender and race/ethnicity. Model 2 was adjusted for variables in Model 1 plus BMI, serum phosphorus, calcium, bicarbonate, albumin, iPTH, total cholesterol and HDL. Model 3 was adjusted for variables in Model 2 plus eGFR, prevalent hypertension, prevalent type 2 diabetes, and use of diuretics and dietary supplements.